A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year.
The University of Queensland-developed vaccine candidate, applied to the skin via the high-density microarray patch (HD-MAP), has produced a protective immune response in dengue-infected mice.
UQ PhD candidate Jovin Choo said the result could lead to a readily administered vaccine that could help halt the devastation of dengue fever globally.
“Dengue is the most significant mosquito-borne viral disease in the world’s tropical zone, infecting 390 million and killing 25,000 annually, resulting in annual estimated economic cost of $8.9 billion,” Ms Choo said.
“While a dengue vaccine technically already exists, it’s only licensed to be used in certain countries where Dengue virus is endemic – and with restricted use.
“So to properly fight this terrible disease, we’ve engineered a vaccine candidate based on a platform technology that uses an Australian insect virus called Binjari virus.”
UQ researchers merged the Binjari and dengue viruses making what’s known as a chimeric virus – an artificial virus – to build the basis of the vaccine which has resulted in some great benefits.
“For instance, the particles exactly mimic the surface of their dengue counterpart, which induces a strong, authentic and protective immune response,” Ms Choo said.
“Also, it allows us to very easily manufacture high yields of the vaccine candidate in mosquito cell culture.
“And it only grows in insect cells, and not mammalian cells, making it extremely safe.”
UQ’s Dr David Muller, one of the senior authors of the research, said another advantage was that the candidate could offer potent antibody responses when delivered via the UQ-developed, Vaxxas Pty Ltd commercialised, HD-MAP system.
“Using the microarray patch, we’re able to employ needle-free delivery of the vaccine to the immune cell-rich layers of the skin with just a click,” he said.
“This targeted delivery allows us to achieve potent neutralising antibody responses using a fraction of a typical dose delivered by injection.
“The ease of administration, coupled with lower dose amounts means that the patch could provide both an efficient and inexpensive vaccination option.”
UQ’s Dr Jody Hobson-Peters said this was only the start with the research team looking to apply these techniques more widely.
“There are four variations of dengue that are closely related, all of which can cause severe disease,” Dr Peters said.
“So we’re now expanding our ongoing pre-clinical studies to all four of these forms of dengue virus.
“And we’re also looking to adapt this technology to other viruses, like Zika virus, West Nile virus and Japanese encephalitis virus.
“These are daunting diseases but cheap, easy and accessible vaccinations for them might one day be just a click away.”
Original Article: Jab-free dengue immunity could be just a click away
More from: University of Queensland
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
High-density microarray patch
- Eosinophilic Esophagitis: the newest esophageal inflammatory diseaseon August 19, 2021 at 5:00 pm
Nat Clin Pract Gastroenterol Hepatol. 2009;6(5):267-278. A thorough history and assessment of allergic diseases is a vital part of the evaluation of a patient with suspected EoE because of the ...
- ‘Cutting-edge’: The Qld scientist hoping to replace jabs with patcheson August 19, 2021 at 10:21 am
As his colleagues in the molecular clamp lab were dusting themselves off and preparing to work on Clamp 2.0, Dr David Muller was experiencing one of the most exciting times of his career.
- Syringe News and Researchon August 18, 2021 at 5:00 pm
Researchers from Australia recently reported a high-density microarray patch used to deliver a SARS-CoV-2 spike subunit vaccine to the skin directly. They used a combination of a SARS-CoV-2 spike ...
- PloS oneon August 16, 2021 at 5:00 pm
Maternal iron-deficiency is associated with premature birth and higher birth weight despite routine antenatal iron supplementation in an urban South African setting: The NuPED prospective study. A ...
- Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayon August 11, 2021 at 5:00 pm
1 Cancer Research Institute, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, MA 02215, USA. 2 Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard ...
Go deeper with Google Headlines on:
High-density microarray patch
Go deeper with Bing News on:
- Lions vs Steelers Live Stream Free| Watch NFL Football Preseason On Air | HD Video Coverage Linkon August 21, 2021 at 10:58 am
Event details about Lions vs Steelers Live Stream Free| Watch NFL Football Preseason On Air | HD Video Coverage Link in San Francisco on August 21, 2021 - watch, listen, photos and tickets ...
- Get More Than $100 Off Lifetime Access To This Award-Winning Documentary Streaming Serviceon August 20, 2021 at 8:24 am
Now, you can get access to thousands of powerful documentaries, for life, with CuriosityStream HD, an award-winning streaming and on-demand platform where you can journey through some of the world’s ...
- Bethesda may just remaster Quake 1 instead of a full remakeon August 19, 2021 at 7:15 am
Bethesda's 'revitalized' Quake may be a Quake 1 remaster on PC with new maps instead of a fully-fledged reboot or remake.
- Golf for HD raises funds for Huntington's disease research, patient programson August 19, 2021 at 3:00 am
Golfers hit the course at Old Orchard Country Club in Mount Prospect for Golf for HD. The event helps fund research and programs for Huntington's disease. Courtesy of Brian Gross Imagine having the ...
- Pick up the Pace With the 10 Best Treadmills for Home Gymson August 18, 2021 at 10:13 pm
A high-end treadmill worthy of a five-star resort or fitness facility is totally within reach for your home gym. And because there's a myriad of solid options in the home treadmill market, we're here ...